Request a demo

NEW! Next-generation T1 & ECV1 Mapping

Designed to make advanced tissue characterization faster, simpler, and more accessible.

Built on decades of cardiovascular MR expertise and shaped by customer feedback, T1 & ECV1 Mapping is the first Medis Suite MR application redesigned on our next-generation software architecture.

It works seamlessly alongside existing Medis Suite MR applications while introducing a modern user experience and establishing the foundation for future innovations across the suite.

1 Research use only in CE Countries.

Try the NEW Medis Suite MR now!

WHAT'S NEW IN T1 AND ECV1 MAPPING

  • Efficient ECV¹ calculation without blood sampling through synthetic hematocrit computation
  • Streamlined workflow for efficient tissue characterization
  • Intelligent automation with transparent clinical review
  • Advanced tissue quantification with customizable, easy-to-interpret visual outputs, supporting greater confidence in image interpretation

Getting the Most Out of T1 & ECV¹ Mapping

Dr. Attila Toth (GOKVI, Budapest, Hungary) shares his perspective on moving beyond image acquisition and the importance of intuitive evaluation tools in the cardiac MR mapping workflow.

Synthetic Hematocrit in Clinical Practice

Dr. Attila Toth (GOKVI, Budapest, Hungary) discusses the practical value of synthetic hematocrit when a current hematocrit value is not available.

EXPLORE THE NEW WORKFLOW

Automated T1 & ECV1 measurements with minimal interaction
- Fully automated T1 & ECV1 Mapping
- Automatic motion correction and co-registration
- Synthetic hematocrit enabled ECV1
- No blood sampling required

Transparent review tools combining automation with clinician oversight
- Easy manual adjustment
- ROI-based quantitative analysis
- Transparent quality control

Advanced quantification and intuitive visualizations
- Global and regional T1 & ECV1 values
- Interactive bullseye visualization
- Seamless reporting workflow

1 Research use only in CE Countries.

SEE MAPPING IN CLINICAL PRACTICE

See how Dr. Attila Toth (GOKVI, Budapest, Hungary) uses T1 & ECV Mapping while reviewing a cardiac amyloidosis case from his clinical practice.

WHY CHOOSE MEDIS SUITE MR?

SCIENTIFIC FOUNDATIONS
• 35+ years of CMR innovation
• Trusted globally by leading centers
• Clinically validated solutions (6,000+ studies)
Try Medis Suite MR now!
USER-CENTRIC WORKFLOWS
• Intuitive user experience
• Standardized workflows
• Faster onboarding
Try Medis Suite MR now!
INTELLIGENT AUTOMATION
• Automated analysis
• Reduced manual effort
• Consistent and reproducible results
Try Medis Suite MR now!
CONTINUOUS INNOVATION
• Ongoing R&D investment
• Unique innovative parameters (HDF, PV Loops, Inward displacement)
• Next-generation platform, future-ready architecture
Try Medis Suite MR now!
Request a demo